US$ 27.89
bpc 157 stability in aqueous solution at room temperature How to Reconstitute BPC-157: Step-by-Step Guide (2026) Buy GLOW Blend (BPC-157 +
Description
A randomised controlled trial published in Clinical Infectious Diseases demonstrated that Thymosin Alpha-1 treatment in severe COVID-19 patients reduced 28-day mortality by 30% compared to standard care alone.17 While this was acute disease, not long COVID, it confirms the biological plausibility of the immune mechanism

, Sikiric, P

Many patients begin with weekly injections for four to six weeks, then transition to monthly maintenance sessions

This allows more granular dose control at very low doses
